Search
Protein S100-B
go.drugbank.com/bio_entities/BE0001177TargetHumansSmall zinc- and- and calcium-binding protein that is highly expressed in astrocytes and constitutes one of the most abundant soluble proteins in brain (PubMed:20950652, PubMed:6487634). Weakly binds calcium but binds zinc very tightly-di...
Synonyms: S-100 protein beta chain, S-100 protein subunit betaMetildigoxin
go.drugbank.com/drugs/DB13401InvestigationalProducts: Lanitop 0,1 mg - Tabletten, Lanitop 0,2 mg - AmpullenAlmotriptan
go.drugbank.com/drugs/DB00918ApprovedIt works by narrowing blood vessels in the brain, stopping pain signals from being sent to the brain, and stopping the release of certain natural substances that cause pain, nausea, and other symptoms
Products: ALMOTRIPTAN EG, Ag-almotriptanCrotamiton
go.drugbank.com/drugs/DB00265ApprovedIt is a colorless to slightly yellowish oil, having a faint amine-like odor. It is miscible with alcohol and with methanol.
Products: EURAX CREAM 10%, Eurax Cream 10%Tetrachlorodecaoxide
go.drugbank.com/drugs/DB05389ApprovedCertain preclinical evidence and clinical pilot data suggest that WF10 may be effective in treating certain cancers. … The trial is being conducted in Germany at the University of Heidelberg and the National Centre for Tumor Diseases.
Products: IMMUNOKINE (WF 10 I.V. SOLUTION)Bretylium
go.drugbank.com/drugs/DB01158ApprovedThe primary mode of action for bretylium is thought to be inhibition of voltage-gated K(+) channels.
Products: Bretylate Inj 50mg/ml, Bretylium Tosylate Inj 50mg/mlPacritinib
go.drugbank.com/drugs/DB11697ApprovedInvestigationalin patients with platelet counts < 50 x 10<sup>9</sup>/L. … has made it a desirable therapeutic target in MF treatment.
Cilgavimab
go.drugbank.com/drugs/DB16393ApprovedInvestigationalmay be exposed to the virus. … Cilgavimab, in combination with [tixagevimab], was issued an FDA emergency use authorization (EUA) on December 9, 2021, for the pre-exposure prophylaxis of COVID-19 in individuals at increased risk for
Tixagevimab
go.drugbank.com/drugs/DB16394ApprovedInvestigationalmay be exposed to the virus. … Tixagevimab, in combination with [cilgavimab], was issued an FDA emergency use authorization (EUA) on December 9, 2021, for the pre-exposure prophylaxis of COVID-19 in individuals at increased risk for
Acetic acid
go.drugbank.com/drugs/DB03166ApprovedInvestigational(Stedman, 26th ed) Acetic acid otic (for the ear) is an antibiotic that treats infections caused by bacteria or fungus. … It is used locally, occasionally internally, as a counterirritant and also as a reagent.
Mixtures: Selectbag One (ax 200 G), AMINOMIX 2 SOLÜSYON, 1000 ML